I-Mab, BCT to work on Arginine Depletion Therapy and Biomarker Study

Drug Discovery |  News | 0 Comment | 04 Feb, 2019

I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune disease...Read more

FDA expands Lilly's ALIMTA Label

Drug Discovery |  News | 0 Comment | 01 Feb, 2019

Eli Lilly and Companyhas announced that USFDA has granted approval for a new indication for ALIMTA® (pemetrexed for injection) in combination with KEYTRUDA® (pembrolizumab...Read more

Neurocrine Biosciences collaborates with Voyager Therapeutics

Drug Discovery |  News | 0 Comment | 31 Jan, 2019

Neurocrine Biosciences and Voyager Therapeutics has announced the formation of a strategic collaboration focused on the development and commercialization of Voyager’s gene therapy pro...Read more

Pfizer and Lilly announce top-line results of Tanezumab

Drug Discovery |  News | 0 Comment | 31 Jan, 2019

Pfizer and Eli Lilly have announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg in patients with moderate-to-severe osteoarthritis (OA) pain. As per ...Read more

J&J announces USFDA approval of IMBRUVICA

Drug Discovery |  News | 0 Comment | 29 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of IMBRUVICA® (ibrutinib) in combination with obinu...Read more

Basilea announces collaboration with Roche

Drug Discovery |  News | 0 Comment | 25 Jan, 2019

Commercial stage biopharma company, Basilea Pharmaceutica has announced that it entered into a collaboration with Roche to explore a combination of Basilea's derazantinib and Roche's PD-L1-...Read more

Wren Therapeutics completes £18M Series A Financing

Drug Discovery |  News | 0 Comment | 23 Jan, 2019

UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases has announced that it has completed a Series A financing round. The ...Read more

AbbVie provides update on Phase 3 Study of IMBRUVICA

Drug Discovery |  News | 0 Comment | 22 Jan, 2019

AbbVie, a research-based global biopharmaceutical company has announced an update on the Phase 3 RESOLVE trial (PCYC-1137) of ibrutinib (IMBRUVICA®) in combination with chemotherapy age...Read more

Everest Medicines signs new deal targeting drug resistance

Drug Discovery |  News | 0 Comment | 14 Jan, 2019

Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacter...Read more

Janssen submits application to EMA seeking approval of STELARA

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Group Type II Variation Application to the European Medicines Agency (EMA) seeking approval o...Read more

Denali Therapeutics announces Phase 1B Study of DNL747

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases has announced initiation of dosing in a Phase 1b ...Read more

Japan approves Amgen's osteoporosis drug

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorization for EVENITY (romosozumab) for the treatment of osteoporosis in pa...Read more

Daiichi Sankyo receives regulatory approval for hypertension tablets

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for esaxerenone tablets, MINN...Read more

Cellular Biomedicine Initiates clinical trial in anti-BCMA CAR-T therapy

Drug Discovery |  News | 0 Comment | 09 Jan, 2019

Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, has announced the initi...Read more

Oculis raises CHF 15.5 million

Drug Discovery |  News | 0 Comment | 08 Jan, 2019

Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments recently announced that it has successfully raised a further CHF15.5 million i...Read more

AbbVie and Tizona Therapeutics announce strategic collaboration

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, strategic collaboration to develop and commercialize CD39-targeted the...Read more

Bristol-Myers Squibb’s Sprycel® tablets now approved for pediatric patients

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ®(dasatinib) tablets to include the treatment of...Read more

AstraZeneca announces phase III trials for roxadustat

Drug Discovery |  News | 0 Comment | 03 Jan, 2019

AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy endpoints for the treatment of patients with anaemia in chronic kidney...Read more